Burden of Chemotherapy Induced Febrile Neutropenia and Role of G-CSF in Febrile Neutropenia in a Low-Income Country: The Children's Hospital Lahore Pakistan Experience

被引：0
|
作者：
Ahmad, A. [1 ,2 ]
Khan, F. S. [3 ,4 ]
Sadiq, M. [3 ,5 ]
机构：
[1] Children Hosp, Lahore, Pakistan
[2] Inst Child Hlth Lahore, Paediat Haematol Oncol, Lahore, Pakistan
[3] Childrens Hosp, Lahore, Pakistan
[4] Inst Child Hlth Lahore Pakistan, Paediat Haematol, Lahore, Pakistan
[5] Inst Child Hlth Lahore Pakistan, Lahore, Pakistan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-052
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] The Optimal Timing and Duration of Daily G-CSF for the Primary Prevention of Febrile Neutropenia in Breast Cancer Patients Undergoing Adjuvant TAC Chemotherapy
    Kim, Zisun
    Hur, Sung Mo
    Lee, Jong Eun
    Han, Sun Wook
    Jung, Hae Il
    Kim, Sung Yong
    Lee, Jihyoun
    Lim, Cheol Wan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [32] Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country
    Prasad, M.
    Chinnaswamy, G.
    Arora, B.
    Vora, T.
    Hawaldar, R.
    Banavali, S.
    INDIAN JOURNAL OF CANCER, 2014, 51 (04) : 432 - U301
  • [33] A RANDOMIZED OPEN LABELED PARALLEL GROUP PHASE III STUDY OF ANTIBIOTICS ALONE VS. ANTIBIOTICS PLUS G-CSF IN PEDIATRIC CANCER PATIENTS WITH FEBRILE NEUTROPENIA IN A LOW-INCOME SETTING
    Arora, B.
    Banavali, S.
    Vora, T.
    Chinnaswamy, G.
    Prasad, M.
    Paradkar, A.
    Kurkure, P. A.
    Havaldar, R.
    Narula, G.
    Talole, S.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S109 - S109
  • [34] A multicentre, randomised trial comparing schedules of G-CSF ( fi lgrastim) administration for primary prophylaxis of chemotherapy -induced febrile neutropenia in early stage breast cancer
    Clemons, M.
    Fergusson, D.
    Simos, D.
    Mates, M.
    Robinson, A.
    Califaretti, N.
    Zibdawi, L.
    Bahl, M.
    Raphael, J.
    Ibrahim, M. F. K.
    Fernandes, R.
    Pitre, L.
    Aseyev, O.
    Stober, C.
    Vandermeer, L.
    Saunders, D.
    Hutton, B.
    Mallick, R.
    Pond, G. R.
    Awan, A.
    Hilton, J.
    ANNALS OF ONCOLOGY, 2020, 31 (07) : 951 - 957
  • [35] Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia
    James A. Chiarotto
    George Dranitsaris
    Supportive Care in Cancer, 2013, 21 : 2727 - 2731
  • [36] Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia
    Chiarotto, James A.
    Dranitsaris, George
    SUPPORTIVE CARE IN CANCER, 2013, 21 (10) : 2727 - 2731
  • [37] Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
    T. Younis
    D. Rayson
    S. Jovanovic
    C. Skedgel
    Breast Cancer Research and Treatment, 2016, 159 : 425 - 432
  • [38] G-CSF as Secondary Prophylaxis of Febrile Neutropenia In the Management of Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Decision-Analysis
    Graczyk, Joanna
    Cheung, Matthew
    Buckstein, Rena
    Chan, Kelvin
    BLOOD, 2010, 116 (21) : 1568 - 1568
  • [39] The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia
    Haim, N
    Shulman, K
    Goldberg, H
    Tsalic, M
    MEDICAL ONCOLOGY, 2005, 22 (03) : 229 - 232
  • [40] Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review
    Younis, T.
    Rayson, D.
    Jovanovic, S.
    Skedgel, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (03) : 425 - 432
12345